Why the study?
The clinical use of doxorubicin is restricted by cumulative, dose-dependent cardiotoxicity, prompting the evaluation of cardioprotective strategies.
Does the combination of Panax ginseng and febuxostat prevent doxorubicin-induced acute cardiotoxicity in rats?
Population
Thirty-five Sprague Dawley male rats
Comparison
P. ginseng, febuxostat, and their combination vs DOX only and normal saline control
Design
Randomized preclinical animal study
Authors
Loading...
May attenuate doxorubicin cardiotoxicity in rats; leaves open human translation and trials.
Does the combination of Panax ginseng and febuxostat prevent doxorubicin-induced acute cardiotoxicity in rats?
The combination of Panax ginseng and febuxostat significantly attenuated doxorubicin-induced acute cardiotoxicity in rats through antioxidant and anti-inflammatory mechanisms.
Al‐kuraishy et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: